I don't think the market has factored in just how near term...

I don't think the market has factored in just how near term revenue is. They probably think, only $3M in the bank, will it last till FDA achieved? However, CE Mark and TGA are already there, what we were waiting upon was scientifically robust clinical trials which are now announced. The PR machine from each of the distributors should now wind up (I think @Red bar already posted a nice article in Greece). Parents of Autistic children can have their lives changed with this device so I expect will be happy to invest in this. And then there will be lobbying for reimbursements from government who also stand to save big dollars from efficient home based Autism treatment.

I was really pleased to see the advice that the new improved stock will be available from August. I expect sales in Q3 and the margin on these devices is fantastic.